Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhoenix Group Holdings Regulatory News (PHNX)

  • There is currently no data for PHNX

Board Changes

25 Aug 2016 07:00

RNS Number : 0802I
Phoenix Group Holdings
25 August 2016
 

 

Phoenix Group Holdings - Board Changes

 

The Board of Phoenix Group Holdings ("Phoenix") is pleased to announce the appointments of three new non-executive directors, Wendy Mayall, John Pollock and Nicholas Shott, all with effect from 1 September 2016.

 

Wendy Mayall has over thirty years' asset management experience, including as Group Chief Investment Officer and latterly consultant at Liverpool Victoria from 2012 to 2015, having previously been Chief Investment Officer for Unilever's UK pension fund from 1996 to 2011 and holding management responsibility for Unilever's pension funds globally. From 2006 to 2009, she was the Chair of the Investment Committee of the Mineworkers Pension Scheme, a British government appointment to one of the largest government backed pension schemes in the UK. Mrs Mayall is the non-executive Senior Independent Director of the Aberdeen UK Tracker Trust plc.

 

John Pollock had a highly successful career in life assurance at the Legal & General Group from 1980 to 2015, including as an executive director of Legal & General Group plc from 2003 to 2015. He held numerous senior roles, gaining wide strategic and technical experience, finally as Chief Executive Officer of LGAS (L&G Assurance Society), one of Legal and Generals' three primary business units, employing 6,000 staff. His previous roles included Chief Executive Officer (Protection and Annuities). Prior to his retirement from Legal and General in 2015, Mr Pollock held positions as Deputy Chair of the FCA Practitioner Panel, Chairman of investment platform Cofunds, and as a non-executive director of the Cala Homes Group.

 

Nicholas Shott is a highly experienced investment banker, who is European Vice Chairman of Lazard, a role he has held since 2007, and Head of UK Investment Banking at Lazard, which he has been since 2009. He joined Lazard in 1991 and became a partner in 1997. His wide experience of successfully advising clients on M&A deals in various sectors over many years is expected to be of significant benefit to Phoenix in pursuing its acquisition strategy.

 

The Phoenix Board also announces that Rene-Pierre Azria will be leaving the Board on 30 November 2016 after seven years as a non-executive director.

 

Commenting on the Board changes, Henry Staunton, Phoenix Chairman said: "I am delighted that we have secured the appointments to the Phoenix Board of three such experienced and successful individuals who will enhance the Board skillset in both quality and diversity. I would like to thank Rene-Pierre Azria for his valuable contribution to Phoenix since his appointment to the Board in September 2009 and through its progress as a premium listed company from July 2010. On behalf of all the Board, I wish him well."

 

No other information is required to be notified under Listing Rule 9.6.13 R.

 

Enquiries:

MediaNeil Bennett, MaitlandPeter Ogden, Maitland+ 44 (0) 20 7379 5151

InvestorsSam Perowne, Head of Investor Relations, Phoenix Group+44 (0) 203 735 0021

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAPIMLTMBITBBF
Date   Source Headline
14th Mar 20259:00 amRNSBoard Change
6th Mar 20253:35 pmRNSDirector/PDMR Shareholding
3rd Mar 202511:12 amRNSTotal Voting Rights
6th Feb 20254:12 pmRNSDirector/PDMR Shareholding
5th Feb 20255:41 pmRNSCompletion of Early Redemption
3rd Feb 20255:47 pmRNSTotal Voting Rights
7th Jan 20252:19 pmRNSDirector/PDMR Shareholding
2nd Jan 202511:00 amRNSTotal Voting Rights
2nd Jan 20258:30 amRNSAnnouncement of Early Redemption
12th Dec 20244:35 pmRNSBlock Listing Application
12th Dec 20244:11 pmRNSBlock listing Return
6th Dec 20245:39 pmRNSDirector/PDMR Shareholding
4th Dec 20249:00 amRNSDirectorate Change
2nd Dec 20241:32 pmRNSTotal Voting Rights
6th Nov 20245:48 pmRNSDirector/PDMR Shareholding
6th Nov 20247:00 amRNSDirectorate Change
5th Nov 20249:22 amRNSDirector/PDMR Shareholding
1st Nov 202412:48 pmRNSDirector/PDMR Shareholding
1st Nov 202412:43 pmRNSTotal Voting Rights
22nd Oct 20244:19 pmRNSDirector/PDMR Shareholding
8th Oct 20245:24 pmRNSDirector/PDMR Shareholding
4th Oct 20243:35 pmRNSDirector/PDMR Shareholding
1st Oct 202410:56 amRNSTotal Voting Rights
18th Sep 202410:56 amRNSDirector/PDMR Shareholding
17th Sep 202411:09 amRNSDirector/PDMR Shareholding
16th Sep 20247:00 amRNS2024 Interim Results
10th Sep 20243:54 pmRNSDirector/PDMR Shareholding
6th Sep 20248:58 amRNSMajor Shareholding
2nd Sep 202411:08 amRNSTotal Voting Rights
28th Aug 20249:16 amRNSDirectorate Change
6th Aug 20245:02 pmRNSDirector/PDMR Shareholding
1st Aug 20241:28 pmRNSTotal Voting Rights
8th Jul 20245:44 pmRNSDirector/PDMR Shareholding
1st Jul 20244:32 pmRNSTotal Voting Rights
26th Jun 20247:00 amRNSPhoenix Group to explore the sale of SunLife
20th Jun 20247:00 amRNSDeleveraging Programme Update
14th Jun 20248:14 amRNSResult of Tender Offer
11th Jun 20241:51 pmRNSBlock listing Return
10th Jun 20244:15 pmRNSPublication of Offering Memorandum
6th Jun 20245:14 pmRNSDirector/PDMR Shareholding
6th Jun 20242:11 pmRNSIssue of debt and tender maximum acceptance amount
5th Jun 20247:29 amRNSTender Offers and New Issue
3rd Jun 20241:27 pmRNSTotal Voting Rights
24th May 202411:05 amRNSDirector/PDMR Shareholding
14th May 20242:43 pmRNSResult of AGM
13th May 20247:00 amRNSDirectorate Change
8th May 20244:33 pmRNSDirector/PDMR Shareholding
3rd May 202411:04 amRNSAnnouncement of Early Redemption
1st May 202411:23 amRNSTotal Voting Rights
12th Apr 20244:41 pmRNSSupplemental Circular to the 2024 Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.